High plasma immunoreactive leptin level in essential hypertension

American Journal of Hypertension

Volumn 10, Issue 10 I, 1997, Pages 1171-1174

  Agata, Jun ^a   Masuda, Atsushi ^a   Takada, Mikio ^a   Higashiura, Katsuhiro ^a   Murakami, Hideyuki ^a   Miyazaki, Yoshinori ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypertension; Hypothalamus; Insulin resistance; Leptin

Indexed keywords

GENE PRODUCT; LEPTIN;

ADULT; ARTICLE; BODY MASS; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; THERMOGENESIS;

ADULT; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PROTEINS;

EID: 0030699352     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00310-5     Document Type: Article

References (15)

1. Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989;149:1514-1520.
3. Halaas JL, Gajiwala KS, Maffei M, et al: Weight-reducing effects of plasma protein encoded by the obese gene. Science 1995;269:543-546.
4. Considine RV, Considine EL, Williams CJ, et al: The hypothalamic leptin receptor in humans. Identification of incidental sequence polymorphisms and absence of db/db mouse and fa/fa rat mutation. Diabetes 1996;45: 992-994.
5. Woods AJ, Stock MJ: Leptin activation in hypothalamus. Nature 1996;381:745.
6. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
7. Campfield LA, Smith FJ, Guisez Y, et al: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Nature 1995;269:546-549.
8. Klein S, Coppack SW, Mohamed-Alli V, Landt M: Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996;45:984-987.
9. Haffner SM, Stem MP, Miettinin H, et al: Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996;45:822-824.
10. Considine RV, Sinha MK, Heiman ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
11. Segal KR, Landt M, Klein S: Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45:988-991.
12. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
13. Stephens TW, Basinski M, Bristow PK, et al: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
14. Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effect of insulin on leptin production in humans. Diabetes 1996;45:699-701.
15. Collins S, Kuhn CM, Petro AE, et al: Role of leptin in fat regulation. Nature 1996;380:677.